Fareston and Pulmonary embolism - a phase IV clinical study of FDA data
Summary:
Pulmonary embolism is reported as a side effect among people who take Fareston (toremifene citrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Breast cancer.
The phase IV clinical study analyzes which people have Pulmonary embolism when taking Fareston. It is created by eHealthMe based on reports of 743 people who have side effects when taking Fareston from the FDA, and is updated regularly.
What is Fareston?
Fareston has active ingredients of toremifene citrate. eHealthMe is studying from 759 Fareston users. Check the latest studies of Fareston.
What is Pulmonary embolism?
Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,334 drugs and 2,959 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.
743 people reported to have side effects when taking Fareston.
Among them, 13 people (1.75%) have Pulmonary embolism.

Among these 13 people:
How long have people been on Fareston when they have Pulmonary embolism? *
- < 1 month: 50.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 16.67 %
- 2 - 5 years: 33.33 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Pulmonary embolism when taking Fareston? *
- female: 92.31 %
- male: 7.69 %
What is the age of people who have Pulmonary embolism when taking Fareston? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 30.77 %
- 50-59: 15.38 %
- 60+: 53.85 %
What are other drugs people take besides Fareston? *
- Zometa: 5 people, 38.46%
- Zyrtec: 3 people, 23.08%
- Prilosec: 3 people, 23.08%
- Coumadin: 3 people, 23.08%
- Diazepam: 3 people, 23.08%
- Femara: 3 people, 23.08%
- Fish Oil: 3 people, 23.08%
- Fluoxetine Hydrochloride: 3 people, 23.08%
- Folic Acid: 3 people, 23.08%
- Levaquin: 3 people, 23.08%
What are other side effects people have besides Pulmonary embolism? *
- Metastases To Bone (cancer spreads to bone): 4 people, 30.77%
- Breast Cancer Recurrent: 4 people, 30.77%
- Oedema Peripheral (superficial swelling): 4 people, 30.77%
- Lymphoedema (localized fluid retention and tissue swelling): 3 people, 23.08%
- Lymphocyte Count Increased: 3 people, 23.08%
- Fistula (an abnormal connection or passageway between two): 3 people, 23.08%
- Gallstones (stone formation by bile component): 3 people, 23.08%
- Gingival Bleeding (bleeding gums): 3 people, 23.08%
- Gingival Ulceration (ulcer on gums): 3 people, 23.08%
- Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 23.08%
What are the existing conditions these people have? *
- Breast Cancer: 3 people, 23.08%
- Metastases To Bone (cancer spreads to bone): 2 people, 15.38%
* Approximation only. Some reports may have incomplete information.
Do you take Fareston and have Pulmonary embolism?
- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Fareston:
- Fareston (759 reports)
Pulmonary embolism treatments and more:
- Pulmonary embolism (160,407 reports)
How severe was Pulmonary embolism and when was it recovered:
Expand to all the drugs that have ingredients of toremifene citrate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Fareston:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pulmonary embolism:
- Pulmonary embolism (2,334 drugs)
Browse all the conditions that are associated with Pulmonary embolism:
- Pulmonary embolism (2,959 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on toremifene citrate (the active ingredients of Fareston) and Fareston (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Simvastatin and Confusion for Women aged 50-59 - now
- Simvastatin and Thinking - Unclear for Women aged 50-59 - a second ago
- Simvastatin and Disorientation for Women aged 50-59 - a second ago
- Simvastatin and Thoughts - Cloudy for Women aged 50-59 - a second ago
- Zopiclone and Citalopram Hydrobromide drug interactions for women aged 50-59 - 4 seconds ago
- Oxcarbazepine and Eye Movements - Uncontrollable for Men aged 20-29 - 4 seconds ago
- Oxcarbazepine and Uncontrolled Eye Movements for Men aged 20-29 - 5 seconds ago
- Oxcarbazepine and Nystagmus for Men aged 20-29 - 5 seconds ago
- Oxcarbazepine and Involuntary Eye Movements for Men aged 20-29 - 5 seconds ago
- Oxcarbazepine and Back And Forth Eye Movements for Men aged 20-29 - 5 seconds ago